Protara Therapeutics Inc (TARA)
$2.48 -1.59% Close Oct 30, 2026 Live
Protara Therapeutics stock today
Protara Therapeutics closed at $2.48 on October 30, 2026, down 1.59% on the day. Over the past year it returned -51.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $139 million.
$2.00$4.00$6.00
NovJan 2026MarMayJulSep
| Period | TARA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -18.7% | -0.9% |
| 3 months | -38.5% | +2.1% |
| Year to date | -53.5% | +11.7% |
| 1 year | -51.8% | +12.4% |
| 3 years | +105.0% | +88.5% |
| 5 years | -64.2% | +76.0% |
Key statistics
- Market value
- $139M
- 52-week range
- $2.32 to $7.56
- Next report
- Nov 10, 2026 (estimated)
About Protara Therapeutics
Biopharmaceutical company developing therapies for rare and orphan diseases.
Sector: Health Care
More on Protara Therapeutics
- Returns: what $1,000 became$1,000 ten years ago is $6.28 today
No forecast, no recommendation. This page describes Protara Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.